Trial intelligence / Profile preview

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children

2015-001776-21Phase 4Completed

Sponsor
Medical University of Vienna
Start
Sep 2015
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of enoxaparin, phenprocoumon and heparin in Phlebothrombosis (2 arms), sponsored by Medical University of Vienna. Started Sep 2015; status: completed.

02

Drugs

enoxaparinphenprocoumonheparin
03

Conditions

Phlebothrombosis

Beyond the preview

Go deeper on 2015-001776-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001776-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call